Evidence map›Paper›PMID 35619922›Full record

ArticleFrontiers in oncology2022

Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study.

Yitao Mao, Qian Pei, Yan Fu, Haipeng Liu, Changyong Chen, Haiping Li, Guanghui Gong, Hongling Yin, Peipei Pang, Huashan Lin and 4 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yitao MaoDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Qian PeiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Yan FuDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Haipeng LiuDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Changyong ChenDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Haiping LiDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Guanghui GongDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Hongling YinDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Peipei PangDepartment of Pharmaceuticals Diagnosis, General Electrics Healthcare, Changsha, China.
Huashan LinDepartment of Pharmaceuticals Diagnosis, General Electrics Healthcare, Changsha, China.
Biaoxiang XuDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Hongyan ZaiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xiaoping YiDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China.
Bihong T ChenDepartment of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Computerized tomography (CT) scans are commonly performed to assist in diagnosis and treatment of locally advanced rectal cancer (LARC). This study assessed the usefulness of pretreatment CT-based radiomics for predicting pathological complete response (pCR) of LARC to neoadjuvant chemoradiotherapy (nCRT). Materials and Methods: Patients with LARC who underwent nCRT followed by total mesorectal excision surgery from July 2010 to December 2018 were enrolled in this retrospective study. A total of 340 radiomic features were extracted from pretreatment contrast-enhanced CT images. The most relevant features to pCR were selected using the least absolute shrinkage and selection operator (LASSO) method and a radiomic signature was generated. Predictive models were built with radiomic features and clinico-pathological variables. Model performance was assessed with decision curve analysis and was validated in an independent cohort. Results: The pCR was achieved in 44 of the 216 consecutive patients (20.4%) in this study. The model with the best performance used both radiomics and clinical variables including radiomic signatures, distance to anal verge, lymphocyte-to-monocyte ratio, and carcinoembryonic antigen. This combined model discriminated between patients with and without pCR with an area under the curve of 0.926 and 0.872 in the training and the validation cohorts, respectively. The combined model also showed better performance than models built with radiomic or clinical variables alone. Conclusion: Our combined predictive model was robust in differentiating patients with and without response to nCRT.

Indexed as

chemoradiationneoadjuvant therapynomogramrectal neoplasmsspiral computed tomography

Identifiers

PMID35619922
PMCPMC9127861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.